[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Soon-Shiong, 1996 - Google Patents

Encapsulated islet cell therapy for the treatment of diabetes: Intraperitoneal injection of islets

Soon-Shiong, 1996

Document ID
16354414075810666990
Author
Soon-Shiong P
Publication year
Publication venue
Journal of controlled release

External Links

Snippet

This report describes the results of the first known report of insulin independence following an intraperitoneal transplantation of encapsulated islets in a Type I diabetic patient (P. Soon- Shiong, R. Heintz, N. Merideth, X. Yao Qiang, Z. Yao, T. Zheng, M. Murphy, M. Moloney, M …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/126—Immunoprotecting barriers, e.g. jackets, diffusion chambers
    • A61K2035/128—Immunoprotecting barriers, e.g. jackets, diffusion chambers capsules, e.g. microcapsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue

Similar Documents

Publication Publication Date Title
Soon-Shiong Treatment of type I diabetes using encapsulated islets
Alagpulinsa et al. Alginate-microencapsulation of human stem cell–derived β cells with CXCL12 prolongs their survival and function in immunocompetent mice without systemic immunosuppression
Mikos et al. Mini‐review: Islet transplantation to create a bioartificial pancreas
Lanza et al. Islet transplantation with immunoisolation
AU725104B2 (en) Retrievable bioartificial implants
Clayton et al. Islet microencapsulation: a review
Sun et al. Microencapsulation of living cells and tissues
EP0742818B1 (en) Macroencapsulated secretory cells
Sun et al. Microencapsulation of living cells—a long-term delivery system
Lanza et al. Treatment of severely diabetic pancreatectomized dogs using a diffusion-based hybrid pancreas
Lysaght et al. Recent progress in immunoisolated cell therapy
EP0641196A4 (en) Microencapsulation of cells.
Fukuda et al. The intraperitoneal space is more favorable than the subcutaneous one for transplanting alginate fiber containing iPS-derived islet-like cells
Brunetti et al. Immunoprotection of pancreatic islet grafts within artificial microcapsules
Mullen et al. Current progress and perspectives in immunoisolated islet transplantation
Maki et al. Novel delivery of pancreatic islet cells to treat insulin-dependent diabetes mellitus
Tatarkiewicz et al. C-peptide responses after meal challenge in mice transplanted with microencapsulated rat islets
Soon-Shiong Encapsulated islet cell therapy for the treatment of diabetes: Intraperitoneal injection of islets
Kendall et al. Islet cell transplantation for the treatment of diabetes mellitus
King et al. The role of capsule composition and biologic responses in the function of transplanted microencapsulated islets of langerhans1
Lanza et al. Encapsulation technologies
Zekorn et al. Islet transplantation in immunoseparating membranes for treatment of insulin-dependent diabetes mellitus
Soon-Shiong et al. Encapsulated Islet Cell Therapy for the Treatment of Diabetes: Intraperitoneal Injection of Islets
Friedman Toward a hybrid artificial pancreas
Iwata et al. Bioartificial pancreas research in Japan